UK Markets close in 3 hrs 5 mins

BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

Helsinki - Helsinki Real-time price. Currency in EUR
Add to watchlist
2.8900+0.1100 (+3.96%)
As of 06:29PM EET. Market open.

BBS-Bioactive Bone Substitutes Oyj

Kiviharjunlenkki 6
Oulu 90220
358 4070 80307

IndustryMedical Devices
Full-time employees17

Key executives

NameTitlePayExercisedYear born
Prof. Ilkka KangasniemiChief Exec. OfficerN/AN/A1964
Ms. Liisa Hukka M.Sc.Chief Financial OfficerN/AN/AN/A
Ms. Hanna Tölli M.Sc., Ph.D.COO, Production Mang. & HR Mang.N/AN/A1983
Mr. Paul C. WatkinsChief Commercial Officer & Member of Advisory BoardN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBON, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was founded in 2003 and is headquartered in Oulu, Finland.

Corporate governance

BBS-Bioactive Bone Substitutes Oyj’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.